Stem Cell Transplant Trial Enrolls First Patient in Minnesota

Stem Cell Transplant Trial Enrolls First Patient in Minnesota

296446

Stem Cell Transplant Trial Enrolls First Patient in Minnesota

A clinical trial investigating patient-derived stem cell transplants for the treatment of people with severe relapsing forms of multiple sclerosis (MS) has enrolled a patient in Minnesota. The patient was enrolled at the University of Minnesota Medical School, one of two trial sites in the state. An additional 18 sites in the U.S. and one in the U.K. also are, or soon will be, recruiting participants for the BEAT-MS Phase 3 trial (NCT04047628). More information is available…

You must be logged in to read/download the full post.